Do you write news releases? And want help?
We offer free pre-publication review of releases. SEE MORE →

September 21, 2018 | Story Review

Newsweek story on Zika vaccine to zap brain cancer is fascinating–but needed more caution about mouse research

The story does express some limitations of the study findings, which we appreciate.

4 Star

GLIOBLASTOMA: ZIKA VIRUS COULD DESTROY BRAIN CANCER THAT KILLED JOHN MCCAIN

September 19, 2018 | Story Review 2

One woman’s account of spinal cord stimulator skips realities of medical device safety in U.S.

The story also did not mention that the author acknowledged being a paid “advocate” for pain patients, which could present a conflict of interest.

2 Star

Here’s how one woman used an implant to get some relief from chronic back pain

September 13, 2018 | Story Review

U.S. News churns out puff piece on medical marijuana app research

The story doesn’t address numerous limitations with this research and failed to scrutinize the quality of the evidence.

2 Star

Study: Medical Marijuana Relieves Range of Symptoms With No Serious Side Effects

September 12, 2018 | Story Review

Reuters story on kidney cancer drug makes us ask: How is this journalism?

The story takes the company’s word for the announced benefit without evaluating the claims and fails to address cost or side effects in any way, despite the fact that both drugs are already on the market.

1 Star

Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer

September 10, 2018 | Story Review

Fish oil during pregnancy led to ‘stronger kids,’ but was the difference clinically meaningful?

The story included multiple independent sources to provide perspective, and it included a few key details about the study.

4 Star

Fish Oil Pills During Pregnancy Might Mean Stronger, Healthier Kids

September 5, 2018 | Story Review 2

In story about ‘latest generation’ of weight loss drugs, NBC overlooks doctors’ pharma ties

Also, a host of potential harms from weight-loss drugs went mostly unmentioned.

2 Star

Weight-loss pills can help. So why don't more people use them?

September 4, 2018 | Story Review

U.S. News & World Report regurgitates news release on cannabidiol and psychosis

The specifics of the study are glossed over, no connection is made between brain activity and clinical symptoms or outcomes, and there’s no mention of cost or potential harms.

2 Star

Cannabidiol Reduces Symptoms of Psychosis

August 29, 2018 | Story Review 2

WSJ reporter claims a carotid artery scan ‘saved’ his life — but there’s no way to know that

Also, discussion of carotid artery screening of people who do not have symptoms is mixed up with the reporter’s experience with testing done in order to diagnose the cause of his symptoms.

2 Star

The Scan That Saved My Life

August 24, 2018 | Story Review

Without an independent source, BuzzFeed’s story on a medical device for OCD doesn’t offer much beyond the news release

On the upside, the story does include the side effects associated with transcranial magnetic stimulation.

3 Star

The FDA Says This Brain-Stimulating Device May Help People With Obsessive-Compulsive Disorder

August 23, 2018 | Story Review

Newsweek’s premature optimism about experimental ovarian cancer drug overlooks costs, harms and limitations of the evidence

While targeted therapies are an important area of research, the public shouldn’t be oversold on early-phase trials or led to think that tumor shrinkage portends a cure.

2 Star

EXPERIMENTAL DRUG VISTUSERTIB COULD SHRINKS TUMORS IN 50% OF OVARIAN CANCER PATIENTS, STUDY SUGGESTS

Toolkit

Tips & Resources for Analyzing Health Care Claims

View More

Toolkit